Australia vs Ireland: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
Ireland
0
in 2020
Australia rank
12th
Ireland rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Ireland
How they compare
Australia currently reports 0.01 against 0 in Ireland, a difference of 0.01.
The two have swapped places 2 times across 9 shared years of data; in 2010 it was Australia ahead.
Australia ranks 12th and Ireland ranks 13th of 52 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.376 | 0.1562 | 0.2198 | Australia |
| 2020s | 0.01 | 0 | 0.01 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Ireland?
- Australia, at 0.01 against 0 in Ireland as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Ireland?
- 0.01, with Australia ahead.
- How many years of comparable data are there for Australia and Ireland?
- 9 years are reported by both, from 2010 to 2020.
- How do Australia and Ireland rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and Ireland ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.